Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8Psoriasis 7Lymphoma, Follicular 4Leukemia 4Myelodysplastic Syndromes 3Asthma 3Vasculitis 2Respiratory Distress Syndrome 2Recurrence 2Pneumonia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Inflammation 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Arthritis, Juvenile 2Wilms Tumor 1Uveitis 1Temporomandibular Joint Disorders 1Spondylitis, Ankylosing 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Metabolic Syndrome 1

Interventions

Megestrol Acetate 4Mirtazapine 2Infliximab 2Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Palonosetron 1Olanzapine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Gemcitabine 1Etanercept 1Eicosapentaenoic Acid 1Dronabinol 1Docetaxel 1Creatine 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anorexia × Etanercept × Clear all
NCT00046904 2011-05-05

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

Mayo Clinic

Phase 3 Completed

Anorexia, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡